Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
electroCore | ECOR | Oct 31, 2024 | 11.40 | -5.08 |
Electromed | ELMD | Oct 31, 2024 | 23.25 | +2.51 |
Electronic Arts | EA | Oct 31, 2024 | 150.85 | +1.15 |
Electrovaya | ELVA | Oct 31, 2024 | 2.06 | -2.83 |
Eledon Pharmaceuticals | ELDN | Oct 31, 2024 | 4.65 | +10.98 |
Element Solutions | ESI | Oct 31, 2024 | 27.10 | -1.85 |
Elevai Labs | ELAB | Oct 31, 2024 | 0.06 | -36.49 |
Elevance Health | ELV | Oct 31, 2024 | 405.76 | -1.22 |
Elevation Oncology | ELEV | Oct 31, 2024 | 0.57 | -4.28 |
Eli Lilly | LLY | Oct 31, 2024 | 829.74 | -2.02 |
Elicio Therapeutics | ELTX | Oct 31, 2024 | 4.26 | +2.40 |
Eliem Therapeutics | ELYM | Oct 31, 2024 | 5.11 | 0.00 |
Ellington Financial | EFC | Oct 31, 2024 | 12.09 | -2.89 |
Ellington Financial | EFC-B | Oct 31, 2024 | 22.80 | +0.13 |
Ellington Financial A Pref | EFC-A | Oct 31, 2024 | 25.07 | -0.08 |
Ellington Financial D Pref | EFC-D | Oct 31, 2024 | 23.19 | 0.00 |
Ellington Financial E Pref | EFC-E | Oct 31, 2024 | 25.41 | +0.08 |
Ellington Financial Pref | EFC-C | Oct 31, 2024 | 25.69 | +0.83 |
Ellington Residential Mortgage REIT | EARN | Oct 31, 2024 | 6.54 | -1.65 |
Ellomay Capital | ELLO | Oct 31, 2024 | 14.20 | +2.38 |
Ellsworth Growth | ECF | Oct 31, 2024 | 9.24 | +0.03 |
Ellsworth Growth A | ECF-A | Oct 31, 2024 | 23.80 | +0.34 |
Elme Communities | ELME | Oct 31, 2024 | 16.87 | -1.92 |
Eltek | ELTK | Oct 31, 2024 | 10.79 | +0.28 |
Elutia | ELUT | Oct 31, 2024 | 3.20 | +0.95 |
Embecta | EMBC | Oct 31, 2024 | 14.08 | -1.74 |
Embotelladora Andina ADR | AKO-B | Oct 31, 2024 | 17.41 | +2.11 |
Embotelladora Andina ADR | AKO-A | Oct 31, 2024 | 13.08 | 0.00 |
Embrace Change Acquisition | EMCG | Oct 31, 2024 | 11.60 | 0.00 |
Embrace Change Acquisition Unit | EMCGU | Oct 31, 2024 | 11.70 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.